| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, ... New England Journal of Medicine 351 (27), 2817-2826, 2004 | 7240 | 2004 |
| Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer EH Romond, EA Perez, J Bryant, VJ Suman, CE Geyer Jr, NE Davidson, ... New England journal of medicine 353 (16), 1673-1684, 2005 | 7105 | 2005 |
| College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer ME Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ... J Clin Oncol 28 (16), 2784-2795, 2010 | 5896* | 2010 |
| Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice … AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ... Journal of clinical oncology 31 (31), 3997-4013, 2013 | 5442 | 2013 |
| Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis P Cortazar, L Zhang, M Untch, K Mehta, JP Costantino, N Wolmark, ... The Lancet 384 (9938), 164-172, 2014 | 4404 | 2014 |
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer AC Wolff, MEH Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ... Journal of clinical oncology 25 (1), 118-145, 2006 | 3832 | 2006 |
| Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer S Paik, G Tang, S Shak, C Kim, J Baker, W Kim, M Cronin, FL Baehner, ... Journal of clinical oncology 24 (23), 3726-3734, 2006 | 3142 | 2006 |
| Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 379 (9814), 432-444, 2012 | 2229 | 2012 |
| Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27 P Rastogi, SJ Anderson, HD Bear, CE Geyer, MS Kahlenberg, ... Journal of Clinical Oncology 26 (5), 778-785, 2008 | 2200 | 2008 |
| Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 379 (2), 111-121, 2018 | 2072 | 2018 |
| Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National cancer Institute 103 (22), 1656-1664, 2011 | 2058 | 2011 |
| Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … DLW Kwong, P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, ... The Lancet, 2014 | 1895 | 2014 |
| Prospective validation of a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 373 (21), 2005-2014, 2015 | 1522 | 2015 |
| Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and … HD Bear, S Anderson, RE Smith, CE Geyer Jr, EP Mamounas, B Fisher, ... Journal of clinical oncology 24 (13), 2019-2027, 2006 | 1251 | 2006 |
| Nanomaterials for theranostics: recent advances and future challenges EK Lim, T Kim, S Paik, S Haam, YM Huh, K Lee Chemical reviews 115 (1), 327-394, 2015 | 1244 | 2015 |
| Use of archived specimens in evaluation of prognostic and predictive biomarkers RM Simon, S Paik, DF Hayes Journal of the National Cancer Institute 101 (21), 1446-1452, 2009 | 1119 | 2009 |
| Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ... The Lancet Oncology 19 (1), 27-39, 2018 | 938 | 2018 |
| erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer S Paik, J Bryant, C Park, B Fisher, E Tan-Chiu, D Hyams, ER Fisher, ... JNCI: Journal of the National Cancer Institute 90 (18), 1361-1370, 1998 | 889 | 1998 |
| Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less B Fisher, J Bryant, JJ Dignam, DL Wickerham, EP Mamounas, ER Fisher, ... Journal of clinical oncology 20 (20), 4141-4149, 2002 | 746 | 2002 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017 | 697 | 2017 |
